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Abstract: Since the beginning of the COVID-19 emergency, the referral Intensive Care Unit for the 
Extracorporeal Membrane Oxygenation (ECMO) support of Piedmont Region (Italy), in cooperation 
with infectious disease specialists, perfusionists and cardiac surgeons, developed a protocol to guar-
antee operator safety during invasive procedures, among which the ECMO positioning or inter-
hospital transport. The use of powered air-purifying respirators, filtering facepiece particles (FFP) 
2–3 masks, protective suits, disposable sterile surgical gowns, and two pairs of sterile gloves as a 
part of a protocol seemed effective and feasible for trained healthcare workers and allow all the 
complex activities connected with the positioning of the ECMO support to be completed effectively. 
The simulation training on donning and doffing procedures and the presence of a dedicated team 
member to verify the compliance with the safety procedure effectively reassured operators and 
likely reduced the risk of self-contamination. From 1 March to 31 December 2020, we used the pro-
cedure in 35 severe acute respiratory distress syndrome (ARDS) patients and one acute respiratory 
failure caused by neoplastic total tracheal obstruction, all positive to COVID-19, to be connected to 
veno-venous ECMO in peripheral hospitals and centralized for ECMO management. This prelimi-
nary experience seems to confirm that the use of ECMO during COVID-19 outbreaks is feasible and 
the risks associated with its positioning and management are sustainable for the health-care work-
ers and safe for patients. 
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1. Introduction 
On 20 February 2020, the first COVID-19 patient was admitted to an intensive care 
unit (ICU) in Italy. 
Pending a definitive confirmation about the effectiveness of ECMO in the context of 
COVID-19 infection [1–4], possible concern emerged about the possibility that ECMO po-
sitioning could be risky for healthcare workers if performed on COVID-19 patients. 
Being the ICU located at ‘Città della Salute e della Scienza’ hospital in Turin (Italy) 
in charge of the management of severe respiratory failure in the Piedmont Region (Italy), 
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an extraordinary consensus process was activated to revise local protocols and protective 
measures routinely applied by the ECMO team. 
Here, we discuss the choices that have been made, the reasons underlying the 
adopted solutions and the experience obtained with their application. 
2. The COVID-19 Context 
At the beginning of the COVID-19 outbreak, both international and national organi-
zations supported the plan to hospitalize suspected or confirmed severe acute respiratory 
syndrome coronavirus 2 (SARS-CoV-2) critical patients in contact and airborne isolation 
whenever possible [5–7]. 
Alternatively, patients should have been admitted to single rooms with sufficient 
space for operators donning and doffing [8]. 
These strategies, used in many facilities during the SARS pandemic, could not be 
applied in the context of the SARS-CoV-2 pandemic. In fact, due to the increasing number 
of patients, entire ICUs have to be dedicated to COVID-19 patients and others have been 
temporarily created and relocated outside the standard contexts. 
3. The Protocol Preparation Phase 
During previous infectious emergencies, exposed health workers developed the dis-
ease (0.6–92% and 1–10% in Ebola and Marburg viruses, respectively) mainly because of 
the inadequacy of personal protective equipment (PPE) and/or exposure to patients with 
unrecognized disease [9]. In the absence of clear evidence about the most adequate ways 
to protect healthcare workers during invasive procedures in patients suffering from 
COVID-19, a group of experts in the field of infectious emergencies was asked to review 
the existing literature on health protection [10]. 
In parallel, a multidisciplinary group involving cardiac surgeons, infectious disease 
specialists, intensivists, perfusionists and critical area nurses designed a training plan to 
allow a team of 4 experts to reach all the personnel of the hospital department possibly 
involved in ECMO management. 
The training course developed at the end of this preparatory work involved the inte-
gration of traditional training supports (local guidelines and flow charts) with the use of 
simulated scenarios and practical exercises. All the personnel involved in ECMO manage-
ment were subjected to a rigorous program, lasting 5 days. 
4. Personal Protective Equipment (PPE): Existing Evidence 
According to the World Health Organization (WHO) [6], European Centre for Dis-
ease Prevention and Control (ECDC) [7] and Extracorporeal Lung Support Organization 
(ELSO) [5], PPE to be worn in case of contact with patients with confirmed or suspected 
SARS-CoV-2 infection should include hair cover, fluid-resistant gown, longer sleeved 
gloves secured to gown by means of vertical tape strips, eye protection, full face shield 
and fit-tested N95/FFP2 or three respirators. Since all clothing worn should be waterproof 
and easy to decontaminate, operating room uniforms to be worn under PPE have been 
suggested. The use of disposable shoes covers is not recommended, due to the increased 
risk of contamination during the undressing phases [8]. 
One area of controversy relates to the use of powered air purifying respirators 
(PAPRs) instead of only N95/FFP masks for aerosol-generating procedures [6]. PAPRs are 
battery-powered blowers providing positive airflow through a filter, cartridge, or canister 
to a hood or face piece, selected on the basis of type and amount of airborne contaminant.  
PAPRs with high-efficiency particulate air (HEPA) or P100 filters have a greater level 
of respiratory protection than N95 masks. Additional advantages associated with the use 
of PAPRs include protection for the head and neck, guaranteed effectiveness even in the 
case of a beard, greater comfort in the case of prolonged use and less risk of displacement. 
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Disadvantages are the greater difficulty of communication, the need for electricity (batter-
ies) to guarantee the correct air flow in the hood and the need to decontaminate the reus-
able parts (batteries, helmet) [11,12]. Currently, WHO [6], ECDC [7] and ELSO [5] guide-
lines do not recommend the use of PAPR. Numerous experiences, however, report favor-
able results in their use, after proper training, in terms of safety and comfort for healthcare 
workers. 
5. ECMO Treatment-Specific Features 
ECMO is a highly skilled operation [2–5]. Considering the initial uncertainties about 
the 2019-nCov transmission, the invasiveness of the procedure, the possible long duration 
of exposure to patients and the possible recurrence of exposure by healthcare personnel 
specialized in ECMO positioning, we decided to provide healthcare workers in charge of 
ECMO missions with infection control precautions, consisting of a disposable waterproof 
suit, waterproof shoe covers and a hood. 
Since the transmission mechanisms of SARS-CoV-2 infection are only partially 
known and given that healthcare workers wearing N95 masks were found to be infected 
after intervening with SARS patients [13], it was decided, in accordance with previous 
experiences [14], to implement the masks N95/FFP2-3 with PAPR Flyte (Stryker-Portage 
MI) with HEPA filters in all situations where high-risk procedures were required, such as 
connection to the ECMO circuit and transfer by ambulance. This is even in spite of the 
evidence from the literature suggesting that the use of PAPRs could be bulky and cum-
bersome, even impacting on the communication effectiveness [13,14]. However, this deci-
sion was made considering the high risk associated with the permanence of a high number 
of health-care workers in confined environments (such as the ambulance) for relatively 
long periods. In addition, the training phase, carried out wearing PPE and PAPR (see be-
low), confirmed that neither manual nor communicative effectiveness was affected by the 
use of these devices. 
6. Personal Protective Equipment Training 
Personnel training is universally considered essential to ensure preparedness and 
success in dealing with a pandemic [15]. In our experience, after adequate PPE training, 
the use of all ECMO-related equipment had be practiced in simulation environment wear-
ing PPE and PAPR. A multidisciplinary team was hence assembled to create a process 
with sterile attire and adapted from the WHO donning and doffing process [16]. The train-
ing procedure was limited to the donning and doffing phases, since no modification to 
the standard ECMO procedure was introduced. The procedures were simulated in a space 
dedicated to training, and therefore in the ward and in the ambulance, with the simulation 
of all personnel roles. 
7. Our Center Donning and Doffing Procedures 
Since it was not possible to identify a real safe area for donning in most ICUs, it was 
prudently decided to carry out most of the PPE donning operations before leaving the 
ECMO center or outside the hospital in which the procedures for connecting to the ECMO 
were expected to take place, as illustrated in Table 1. Our enhanced droplet/airborne PPE 
procedure incorporates the use of PAPR with HEPA filters for ECMO positioning (Figure 
1). 
An additional intensivist was assigned the task of supervising each phase of the PPE 
management during the mission. Specifically, it was his responsibility: during the don-
ning phase, to verify the complete adherence to the protocol; during the doffing phase, to 
check the integrity of the PPE removed. During the doffing phase, this support figure was 
also assigned the task of supporting healthcare workers in the removal of any contami-
nated PPE item (“dofficer” role), since the doffing procedure is particularly at risk of con-
tamination for the healthcare worker.  
Membranes 2021, 11, 334 4 of 7 
 
 
Our choice is supported by literature evidence. In fact, according to Verbeek et al., 
additional spoken instruction may lead to fewer errors in doffing (MD −0.9, 95% CI −1.4 
to −0.4). Face-to-face instruction may reduce non-compliance with doffing guidance more 
(odds ratio 0.45, 95% CI 0.21−0.98) than providing folders or videos only [17], especially 
during the doffing procedure, that is particularly at risk of possible contamination for the 
healthcare professional, as emerged from the Ebola virus experience [18]. 
In cases where ECMO had to be positioned at another health Centre, the team should 
carry the PPE and PAPR resources with them to avoid the use of the not perfectly known 
equipment of another hospital. Personnel performing ECMO cannulation must wear ster-
ile attire in addition to PPE, worn before starting the procedure in the patient′s room. 
 
Figure 1. Enhanced droplet/airborne Personal Protective Equipment incorporating use of Powered 
Air Purifying Respirator (PAPR) for ECMO positioning. The healthcare staff wear impermeable 
disposable coveralls with impermeable overshoes and special waterproof hoods and surgical 
masks, which are worn over the headgear and FFP2-3 mask (A). The PAPR system is worn over 
the hood of the suit and PAPR blower unit, made by plastic helmet (B) with battery on belt (C) 
and covered by a hood with a filter material (D). Completed PPE includes a sterile gown and ster-
ile gloves (E). 
Table 1. Steps to put on/take off personal protective equipment (PPE) for ECMO procedures in patients with COVID-19. 
Context Put On Context Take OFF 
Before leav-
ing 
- Satisfy primary needs 
- Remove jewelry/personal items, keep hair up and
beard shaved 
- Perform hand hygiene 
- Put on the cap/head cover 
- Use the washable clogs with back strap 
- Put on the white impermeable overshoes 
- Place the white impermeable disposable coverall
over the uniform (the second operator looks at the
right closing of zip) 








- Remove the external gloves 
- Remove the sterile gown 
- Perform hand hygiene by rubbing with anti-
septic gel (on the internal gloves) 
- Remove the external disposable overshoes
(with new non-sterile gloves or by the second 
operator) 
- Put on a new impermeable gown 
- Put on the second gloves 
- Check the Flyte battery c before leaving the 
ICU 
N.B. Final check of PPE by a second operator 









N.B. Assistance of a second trained operator needed 
- Perform hand hygiene 
- Put on the FFP2/3 mask 
- Put on the white hood of the coverall 
o Fix the strips on the head 
o Fix the double strips of the mask and verify its ad-
hesion to the face 
o Fix the inferior thorax strips anteriorly 
- Put on the sterile gloves 




All the health-care team is wearing the full op-




- Adjust the helmet Flyte b to the head circumference 
- Put on the helmet Flyte 
o Check the size 
o Connect the battery 
o Verify functioning 
- Put on the helmet Flyte cover and be careful to fix it
properly 
o Test the air flow 
- Put on the sterile gown 
- Put on the sterile gloves 
- N.B. Final check of PPE by a second operator 
After arri-




N.B. Assistance of a second operator, wearing 
proper PPE. Change gloves after each contami-
nated contact 
- Remove the external gown and gloves 
- Perform hand hygiene by rubbing with anti-
septic gel (on the internal gloves) 
- While the first operator is sitting with his eyes
closed, the second one, using movements for
back to front and from top to bottom, unfas-
tens and removes the Flyte helmet cover 
o Unfasten and disconnect the battery and place
it in a designated container for its cleaning 
o Remove the Flyte helmet and place it in a des-
ignated container for its cleaning  
- Remove the white hood of the coverall 
- Remove the white coverall (the anterior zip
should be opened by the second operator) and
the internal gloves, simultaneously (because 
of the patch previously positioned) 
- Removal of the impermeable overshoes by the
second operator (first operator sits on a plastic
chair/support) 
- Remove the FFP2/3 mask and the cap/head
cover 
- Remove the gloves and perform hand hygiene
a The addition of the disposable overshoes is intended for mechanical protection only—i.e., to avoid traumatic damage of 
the impermeable overshoes. b We used the Flyte ® Steri-Shield ® personal protection system (Stryker). For more infor-
mation: Available online: https://www.strykermeded.com/media/1082/flyte-sterishield-system-brochure.pdf (accessed on 
30 April 2021). c For the management of the Flyte battery, follow manufacturer’s instructions. The battery replacement is 
performed by the second operator, wearing the proper PPE (impermeable gown—double gloves—goggles-face shield—
head cover—FFP2-3 mask), opening the back of the first operator’s sterile gown and paying attention not to contaminate 
the battery. In the cleaning process, the battery and the Flyte helmet cannot be dipped into the water; pay attention to the 
electrical connections. d Support staff members (ambulance driver, stretcher bearers) wear coveralls, FFP2 masks, visors 
and gloves, upon arrival at target hospital until admission at our Hospital. List of abbreviations: PPE, personal protective 
equipment; ECMO, extracorporeal membrane oxygenation; COVID-19, coronavirus disease 2019; ICU, intensive care unit; 
FFP2/3, filtering face piece 2/3; PAPR, powered air-purifying respirator. 
8. Preliminary Experience after Implementation of the Protocol 
From 1 March to 31 December 2020, we used the procedure in 35 severe acute respir-
atory distress syndrome (ARDS) patients and one acute respiratory failure caused by ne-
oplastic total tracheal obstruction, all suffering from pneumonia by 2019-nCoV, confirmed 
by the real-time polymerase-chain-reaction (RT-PCR) on at least one low respiratory tract 
specimen [19]. 
A protocol including the use of PAPRs, FFP 2-3 masks, protective suits, disposable 
sterile surgical gowns, and two pairs of sterile gloves (Figure 1) seems effective in protect-
ing against the risk of contamination and allows full personnel ability of performing all 
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ECMO-related procedures. All the involved staff (consisting of one anesthesiologist, car-
diac surgeon, nurse and perfusionist) work in the patient room. Communication between 
the team members seems feasible with PAPRs. No major technical problems nor SARS-
CoV-2 health care infection are reported in the involved staff. 
Considering its feasibility, the approach proposed here has subsequently been ex-
tended to all procedures associated with a possible elevated risk of contamination when 
performed in COVID-19 patients. 
9. Conclusions 
Risks of contamination associated with the positioning and management of the 
ECMO in patients infected with 2019-nCov seem sustainable for the staff involved and 
safe for patients.  
Personnel training is essential and all ECMO-related equipment needs to be practiced 
in simulation environment wearing PPE and PAPRs. 
10. Key Messages 
• ECMO positioning deserves a specific effort in identifying appropriate PPE proce-
dures being an invasive and long-lasting procedure, often repeated by experienced 
healthcare professionals  
• A protocol including the use of powered air-purifying respirators, FFP 2-3 masks, 
protective suits, disposable sterile surgical gowns, and two pairs of sterile gloves is 
effective in protecting against the risk of contamination and allows full personnel 
ability of performing all ECMO-related procedures 
• Personnel training is essential and all ECMO-related equipment need to be practiced 
in a simulation environment wearing personal protective equipment and powered 
air-purifying respirators. 
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